|[October 26, 2012]
Simulations Plus Announces Next Quarterly Cash Dividend
LANCASTER, Calif. --(Business Wire)--
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation
and modeling software for pharmaceutical discovery and development,
today announced that its board of directors has declared its next
ongoing quarterly cash dividend of $0.05 per share to its shareholders
will be distributed on Tuesday, November 13, 2012, for shareholders of
record as of Thursday, November 8, 2012.
Walt Woltosz, chairman and chief executive officer of Simulations Plus,
said: "Our board of directors has approved the next quarterly cash
dividend of $0.05 per share. This next dividend distribution will be our
fourth beginning with the initial distribution in March of this year.
Our cash position remains strong at over $13 million as of today, even
after paying out nearly $2.4 million in dividends in the three previous
distributions. This dividend, like the other three, will amount to a
distribution of just under $800,000. Please note that the board of
directors may elect to continue or discontinue these dividends at any
time in response to other opportunities to invest cash r for any other
About Simulations Plus, Inc.
Simulations Plus, Inc., is a premier developer of groundbreaking drug
discovery and development simulation and modeling software, which is
licensed to and used in the conduct of drug research by major
pharmaceutical, biotechnology, agrochemical, and food industry companies
worldwide. The Company also provides a productivity tool called
Abbreviate! for PCs. Simulations Plus, Inc., is headquartered in
Southern California and trades on the NASDAQ Capital Market under the
symbol "SLP." For more information, visit our Web site at www.simulations-plus.com.
Safe Harbor Statement Under the Private Securities Litigation Reform
Act of 1995 - With the exception of historical information, the
matters discussed in this press release are forward-looking statements
that involve a number of risks and uncertainties. Words like "believe,"
"expect" and "anticipate" mean that these are our best estimates as of
this writing, but that there can be no assurances that expected or
anticipated results or events will actually take place, so our actual
future results could differ significantly from those statements. Factors
that could cause or contribute to such differences include, but are not
limited to: our ability to maintain our competitive advantages,
acceptance of new software and improved versions of our existing
software by our customers, the general economics of the pharmaceutical
industry, our ability to finance growth, our ability to continue to
attract and retain highly qualified technical staff, our ability to
identify and close acquisitions on terms favorable to the Company, and a
sustainable market. Further information on our risk factors is contained
in our quarterly and annual reports as filed with the U.S. Securities
and Exchange Commission.
[ Back To greentechnologyworld.com's Homepage ]